Prognostication for meningiomas: H3K27me3 to the rescue?
Neuro Oncol
.
2021 Aug 2;23(8):1218-1219.
doi: 10.1093/neuonc/noab083.
Authors
Sandro Santagata
1
2
3
4
,
Keith L Ligon
1
2
3
4
Affiliations
1
Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
2
Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
3
Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA.
4
Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
33822195
PMCID:
PMC8328006
DOI:
10.1093/neuonc/noab083
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers, Tumor
Histones
Humans
Meningeal Neoplasms* / diagnosis
Meningioma* / diagnosis
Substances
Biomarkers, Tumor
Histones